Biogazelle's microRNA Quantification Service

Jun 12, 2015

Biogazelle is now offering massively parallel sequencing to quantify microRNAs in compromised samples characterized by degraded RNA or low output amounts. The service offering comibnes optimal library preparation and purification, so that sequencing reads are actually spent on mature microRNAs, and not on undesirable contaminants such as ribosomal and other long RNA fragments, the company said. Further, raw data reads are processed and analyzed using Ant, Biogazelle's custom small RNA sequencing analysis pipeline that is part of Cobra, its RNA sequencing data-analysis platform.

Participants of the program will be able to send a representative sample that will be sequenced at very high coverage in order to determine the biomarker potential and optimal sequencing depth for future studies, Biogazelle said.

More Like This

Aug 17, 2018

HTG EdgeSeq Precision Immuno-Oncology Panel

HTG Molecular Diagnostics has launched the HTG EdgeSeq Precision Immuno-Oncology Panel, a research-use-only profiling panel that provides a large, comprhensive set of genes involved in the host immune response to tumors. Using a single 5-µm formalin-fixed, paraffin-embedded tissue section, the panel profiles 1,392 genes, without the RNA extraction and complex workflow associated with standard RNA-seq methods. Researchers can use the panel to go from raw sample to sequencing-ready libraries in as little as 36 hours, with less than four hours of hands-on time, HTG said. Applications include the immunophenotyping of tumor infiltrating lymphocytes; monitoring of immunotherapy response biomarkers; and the elucidation of immune-escape mechanisms known to drive disease progression. 

Aug 16, 2018

IncellDx BioINK PD-L1 CTC Core Kit

IncellDx has launched its BioINK PD-L1 CTC Core Kit, a complete, pre-optimized tool to identify, enumerate, and quantify PD-L1 expression in circulating tumor cells. According to the firm, the kit includes the addition of a separate quantitative control cell cocktail — called OncoTect iO Control Cells — that combines PD-L1 positive epithelial cells, PD-L1 negative epithelial cells, and peripheral blood mononuclear cells. The tool allows labs to assess linearity and lower limits of detection for CTC enumeration with known quantities of cells in a lyophilized standard.

The firm's BioINK technology enables highly sensitive and specific quantification of protein or mRNA expression at a single-cell-by-cell resolution optimized for microfluidic chips. 

Aug 13, 2018

Empirical Bioscience EB Pure Agarose Gel Extraction Kit

Empirical Bioscience has introduced the EB Pure Agarose Gel Extraction Kit, which is designed to isolate small DNA fragments (70 bp to 20 kb) from agarose gel in 15 minutes. The system specifically but reversibly binds DNA or RNA under optimized conditions, allowing proteins and other contaminants to be removed. Empirical claims the process will help guarantee consistent recovery rates in more than 85 percent of cases, while simultaneously removing primer-dimers, primers, nucleotides, proteins, salt, agarose, ethidium bromide, and other impurities. The extracted DNA can be used in most applications including ligations, PCR, sequencing, restriction digestion, or various labeling reactions, the firm said.

Aug 10, 2018

Helomics Precision Oncology Insights Program

Helomics announced that it has launched its new Precision Oncology Insights platform, which provides a personalized oncology roadmap for oncologists and their patients. Having been acquired by Precision Therapeutics in June, Helomics will offer the platform as a tool to test living tumor tissue from the patient to determine how the tumors respond to drugs. Helomics then integrates the drug response with other genomic and molecular data. The firm's artificial intelligence knowledge base, D-CHIP (Dynamic Clinical Health Insights), then analyzes the data to generate a roadmap that provides additional context to help personalize patient treatment.

Aug 07, 2018

Oxford Gene Technology SureSeq Interpret

Oxford Gene Technology has launched its SureSeq Interpret software for next-generation sequencing data analysis. The software was designed for use with the SureSeq NGS panels and is included with the purchase of the panels. For calling mutations with a greater than 1 percent variant allele frequency, the software has 100 percent sensitivity and 99.9 percent specificity. It can call SNVs, indels, and structural variants.

Aug 03, 2018

Enpicom ImmunoGenomix Platform

Dutch bioinformatics software engineering company Enpicom has released the first version of its ImmunoGenomix platform to support the development of immunotherapies, as well as patient stratification and treatment monitoring. The firm will expand the platform into a comprehensive immunosequencing data analysis platform designed to analyze, monitor, and compare the immune repertoires in the context of immunotherapy development and at all stages of treatment and disease over time. The platform will enable customers to use their own sample preparation protocols and preferred next-generation sequencing technology.

Aug 03, 2018

BD AbSeq Assay

Becton Dickinson has announced the commercial release of its BD AbSeq assay, which will analyze protein expression at the single-cell level using high-throughput sequencing. The assay integrates high-quality antibodies from the BD Pharmingen portfolio with oligonucleotides, allowing researchers to perform single-cell analysis on the firm's Rhapsody single-cell analysis system. When used in tandem, the tools allow researchers to simultaneously analyze RNA and proteins in thousands of individual cells and develop a clearer picture of the role genes and proteins play in biological systems. 

Jul 26, 2018

MedTek21 Version 4.0

MedTek21 has introduced version 4.0 of its eponymous medication management platform for precision medicine, which includes drug-to-gene monitoring. The new release adds reporting for patients at risk for harmful pharmacogenomic interactions as well as real-time alerts either through electronic health records systems or a standalone application. MedTek21 version 4.0 also features two-way integration with Epic Systems and Cerner EHRs and several popular pharmacy information systems. 

Jul 26, 2018

Asuragen AmplideX PCR/CE SMN1 Kit

Asuragen has announced the launch of its AmplideX PCR/CE SMN1 Kit. The kit provides a simple and scalable determination of functional SMN1 copy number within four hours. The assay is compatible with Thermo Fisher Scientific Applied Biosystem capillary electrophoresis instruments and leverages Asuragen's AmplideX Reporter software to automate and streamline reporting of results.

Jul 26, 2018

Biofortuna AmpDRY Air-Dried Master Mix

Biofortuna announced today that it will launch its ampDRY master mix for PCR applications at the American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo 2018. The firm has developed its ampDRY hot-start master mix to allow complete endpoint or real-time PCR assays to be stabilized in a dry format at ambient temperatures for at least 12 months. Biofortuna said that it also offers full in vitro diagnostic contract manufacturing services using ampDRY, and can customize the manufacturing process to match customer requirements and develop bespoke, cost-effective stabilized products. 

Jul 25, 2018

SeraCare AccuSpan HCV RNA Linearity Panel

SeraCare has expanded its AccuPlex line with the launch of the AccuSpan HCV RNA Linearity Panel. The eight-member panel has been qualified against World Health Organization standards and is made from serial dilutions of high-titer recombinant hepatitis C virus, genotype 1b, with established reactivity for HCV RNA, and one negative control. The panel can be used by researchers, diagnostics manufacturers, and clinical labs to develop, evaluate, and validate HCV molecular test methods. The panel is useful for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, assessing lot-to-lot variability of kits, performing linearity studies, or any time there may be deterioration in diagnostic assays, according to the firm. It uses SeraCare's proprietary AccuPlex technology, which packages recombinant viral material in a way that is stable, replication-deficient, non-infectious, and mimics a real patient sample throughout the diagnostic workflow.

Jul 24, 2018

Microbiologics Molecular Diagnostics QC Panels

Microbiologics has launched new panels for the verification and routine quality control of common molecular assays. They include four panels for women's health and sexually transmitted infection testing: a human papillomavirus control panel; human papillomavirus verifcation panel; vaginal control panel; and vaginal verification panel. The company also launched new panels for blood culture identification and gastrointestinal testing: a blood culture control panel; blood culture verification panel; enteric viral control panel; and enteric viral verification panel. The new panels are designed to mimic patient sample processing, Microbiologics said. 

Jul 20, 2018

Sage Bionetworks Agora Platform

Sage Bionetworks has launched the Agora platform, a web-based tool that allows researchers to explore curated genomic analyses of Alzheimer's disease. The analyses resulted from the Accelerating Medicines Partnership – Alzheimer's Disease (AMP-AD) Target Discovery and Preclinical Validation Project, a public-private partnership led by the National Institute on Aging and managed by the Foundation for the NIH (FNIH). Through the Agora portal, which will be frequently updated, the analyses are now available to researchers outside the AMP-AD consortium. The initial release includes differential expression and co-expression network meta-analyses across four human RNA sequence data sets. Future releases will include human proteomic and metabolomic analyses, comparative evaluations of disease signatures across species, and druggability and tractability information to guide the selection of targets for early drug discovery.

Jul 19, 2018

Swift Biosciences 2S Turbo Library Kit

Swift Biosciences is now offering early access to its Swift 2S Turbo Library Kit. The kit enables researchers to complete library prep workflow in two hours with as low as 1 ng of input. Researchers can use a range of sample types, including fresh and fresh-frozen tissue, human or microbial genomic DNA, formalin-fixed paraffin-embedded samples, and PCR amplicons.

Jul 18, 2018

MNG Laboratories Comprehensive Intellectual Disability/Autism Panel

MNG Laboratories has added mitochondrial DNA sequencing and deletion analysis to its Comprehensive Intellectual Disability/Autism next-generation sequencing panel at no additional cost.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.